Pittenger & Anderson Inc’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$14.9M Sell
67,557
-3,753
-5% -$1.04M 0.53% 59
2026
Q1
$21.1M Buy
71,310
+608
+0.9% +$181K 0.84% 41
2025
Q4
$19.3M Buy
70,702
+2,123
+3% +$577K 0.74% 43
2025
Q3
$18.5M Buy
68,579
+1,025
+2% +$279K 0.68% 42
2025
Q2
$18.6M Buy
67,554
+1,511
+2% +$411K 0.68% 41
2025
Q1
$17.5M Sell
66,043
-19
-0% -$4.69K 0.64% 41
2024
Q4
$15.3M Buy
66,062
+482
+0.7% +$111K 0.56% 47
2024
Q3
$14.5M Sell
65,580
-1,089
-2% -$225K 0.54% 49
2024
Q2
$13.1M Sell
66,669
-1,765
-3% -$365K 0.54% 54
2024
Q1
$14.7M Buy
68,434
+1,180
+2% +$248K 0.6% 48
2023
Q4
$14.2M Buy
67,254
+359
+0.5% +$76.6K 0.63% 46
2023
Q3
$13.4M Sell
66,895
-1,109
-2% -$220K 0.68% 43
2023
Q2
$12.6M Buy
68,004
+293
+0.4% +$54.1K 0.61% 51
2023
Q1
$13M Buy
67,711
+1,729
+3% +$313K 0.67% 45
2022
Q4
$11.1M Buy
65,982
+15,103
+30% +$2.62M 0.61% 52
2022
Q3
$9.01M Sell
50,879
-509
-1% -$101K 0.54% 58
2022
Q2
$10.5M Buy
51,388
+1,128
+2% +$239K 0.61% 52
2022
Q1
$12M Buy
50,260
+3,701
+8% +$869K 0.59% 56
2021
Q4
$10.6M Buy
46,559
+966
+2% +$213K 0.49% 62
2021
Q3
$8.82M Buy
45,593
+1,469
+3% +$298K 0.44% 69
2021
Q2
$9.38M Buy
44,124
+219
+0.5% +$46.2K 0.48% 64
2021
Q1
$8.97M Sell
43,905
-25,177
-36% -$4.96M 0.48% 63
2020
Q4
$12.6M Buy
69,082
+3,476
+5% +$591K 0.71% 34
2020
Q3
$11M Buy
65,606
+3,122
+5% +$526K 0.7% 37
2020
Q2
$10.2M Buy
62,484
+2,080
+3% +$373K 0.71% 33
2020
Q1
$10.4M Sell
60,404
-276
-0.5% -$54.9K 0.89% 25
2019
Q4
$12.2M Buy
60,680
+346
+0.6% +$71K 0.81% 24
2019
Q3
$12.8M Sell
60,334
-285
-0.5% -$59.5K 0.92% 22
2019
Q2
$11.8M Sell
60,619
-1,124
-2% -$207K 0.88% 23
2019
Q1
$10.2M Buy
61,743
+455
+0.7% +$80.4K 0.79% 28
2018
Q4
$11.5M Sell
61,288
-108
-0.2% -$19.9K 1.06% 15
2018
Q3
$10.4M Buy
61,396
+790
+1% +$133K 0.82% 22
2018
Q2
$9.94M Sell
60,606
-305
-0.5% -$49.8K 0.85% 21
2018
Q1
$9.85M Buy
60,911
+865
+1% +$138K 0.86% 21
2017
Q4
$8.77M Buy
60,046
+1,116
+2% +$159K 0.77% 26
2017
Q3
$8M Buy
58,930
+2,175
+4% +$275K 0.73% 27
2017
Q2
$7.11M Buy
56,755
+12,360
+28% +$1.48M 0.68% 29
2017
Q1
$5.27M Buy
44,395
+3,640
+9% +$438K 0.53% 49
2016
Q4
$4.7M Buy
40,755
+22,415
+122% +$2.49M 0.5% 52
2016
Q3
$1.92M Buy
18,340
+17,765
+3,090% +$1.85M 0.21% 121
2016
Q2
$56K Hold
575
0.01% 262
2016
Q1
$55K Hold
575
0.01% 287
2015
Q4
$52K Sell
575
-395
-41% -$37.2K 0.01% 300
2015
Q3
$90K Sell
970
-390
-29% -$37.1K 0.01% 280
2015
Q2
$127K Sell
1,360
-745
-35% -$69.5K 0.02% 273
2015
Q1
$199K Sell
2,105
-130
-6% -$12K 0.03% 253
2014
Q4
$198K Buy
+2,235
New +$189K 0.03% 244

Other funds holding CME

Pittenger & Anderson Inc's CME Position: Q2 2026 in Review

Pittenger & Anderson Inc reduced its CME Group (CME) stake by 5.3% in Q2 2026, selling an estimated $1.04M and leaving 67,557 shares worth $14.9M. The position accounts for 0.53% of the portfolio, ranked #59.

Pittenger & Anderson Inc first reported a position in CME in Q4 2014 and has held it in 47 quarters since. The position peaked at $21.1M in Q1 2026. 1,698 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Pittenger & Anderson Inc held 67,557 shares of CME Group worth $14.9M as of Q2 2026.
  • Pittenger & Anderson Inc sold 3,753 CME Group shares in Q2 2026, an estimated $1.04M.
  • CME Group made up 0.53% of Pittenger & Anderson Inc's portfolio in Q2 2026, its #59 holding.
  • Pittenger & Anderson Inc first reported a position in CME Group in Q4 2014 and has held it in 47 quarters since.
  • Pittenger & Anderson Inc's CME Group position peaked at $21.1M in Q1 2026.
  • 1,698 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Pittenger & Anderson Inc's 13F filing for Q2 2026, filed 27 Jul 2026.